Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-021392
Filing Date
2018-05-02
Accepted
2018-05-02 21:04:40
Documents
2
Period of Report
2018-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 12309
2 POWER OF ATTORNEY. burow_poa.htm EX-24 8558
  Complete submission text file 0001140361-18-021392.txt   22367
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Issuer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
Burow Kristina (Reporting) CIK: 0001569248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38470 | Film No.: 18801508